Chemotherapy RPM

Monitoring neutropenic fever to prevent rehospitalization post-treatment

Neutropenic fever is a common occurrence following chemotherapy treatment. In some cases, the fever can become serious enough to require hospitalization.

This study correlates multiple parameters continuously captured by our ECG and axillary temperature monitors to detect and predict an impending event up to 18 hours in advance.

Customizable solution

Customized patient app
Data integration options
Flexible data formats
Data support services

chemotherapy-rpm-trials

Logistical support

Sensors directly shipped to sites
Ready to go, pre-provisioned devices
Training
Technical support

vitals-data

Vivalink's connected wearable devices enable us to correlate multiple patient data points into an integrated solution for post-cancer therapy monitoring."

-Shawn Zhou, CEO of AlacrityCare

Want more? Learn how Vivalink can help your company.

CONNECT WITH A SPECIALIST